Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection
09 janv. 2022 12h00 HE
|
Exagen Inc.
SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a...
Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
17 nov. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Piper Sandler 33rd Annual Virtual...
Exagen Inc. Reports Third Quarter 2021 Results
10 nov. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2021....
Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021
27 oct. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2021...
Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus
27 oct. 2021 08h25 HE
|
Exagen Inc.
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® CTD and AVISE Lupus are a contracted covered...
Exagen Inc. Announces $27.2 Million Debt Refinancing
25 oct. 2021 08h25 HE
|
Exagen Inc.
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that it entered into an amendment to its loan and security...
Exagen to Present at Cowen and Company 40th Annual Healthcare Conference
18 févr. 2020 08h25 HE
|
Exagen, Inc.
SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Announces Addition to Russell 3000® and 2000® Indexes
16 déc. 2019 08h25 HE
|
Exagen, Inc.
SAN DIEGO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
30 oct. 2018 10h30 HE
|
Exagen Diagnostics, Inc.
Albuquerque, NM and San Diego, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that President and Chief Executive Officer, Ron Rocca,...
Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test
20 août 2018 11h20 HE
|
Exagen Diagnostics, Inc.
Albuquerque and San Diego, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test, see full...